摘要
目的:观察硝苯地平控释片(Nif-CR)治疗无痛性心肌缺血(SMI)时对左心功能的影响。方法:36例SMI病人(男性23例,女性13例;年龄56±s7a)采用Nif-CR20mg,po,q12h×3wk。结果:(1)舒张压从125±2.3kPa下降至9.7±2.3kPa(P<0.05);缺血型ST段压低明显改善(从1.6±0.7mm升至1.0±0.6mm)(P<0.01)。(2)核素心功能检测,LVEF,SV,ER,PFR及RCO均显著改善(P<0.05或P<0.01)。(3)治疗后PRA和ANGⅡ水平降低(P<0.05)。结论:Nif-CR的持久血药浓度可改善左心功能,降低血压。不良反应小。
AIM : To observe the effects of nifedipine controlled release(Nif-CR) tablet on left cardiac function in patients with silent myocardial ischemia. METHODS: Thirty-six patients(M 23, F 13; age 56± s 7 a) were given Nif-CR 20 mg,po, q 12 h for 3 wk. RESULTS : After the treatment HR and SBP decreased moderately, DBP and MAP decreased markedly(P<0.05); the ischemic ST segments in ECG improved obviously(from 1.6± 0.7 mm to 1.0± 0.6 mm)(P<0.01); the nuclide cardiac function tests showed increasing LVEF(left ventricular ejection fraction), SV(stroke volume), ER(ejection rate), PFR(peak filling rate), and RCO(relative cardiac output)(P< 0.05,or P < 0.01); before treartment the plasma PRA(plasma renin activity)and ANG Ⅱ(angiotensin Ⅱ) level were elevated,after treatment were lowered down (P < 0.05). CONCLUSION: The sustained blood concentration of Nif-CR can improve left cardiac function and lower blood pressure. The adverse reaction are mild.
出处
《新药与临床》
CSCD
北大核心
1995年第4期200-202,共3页
关键词
硝苯地区
心肌缺血
心脏功能试验
迟效制剂
nifedipine
myocardial ischemia
heart function tests
delayed-action preparations
angiotensin Ⅱ